Sort
48,018 grants matching “immunotherapy”
Peptide vaccine immunotherapy for children with recurrent low-grade astrocytomas
$357,496Ian F. Pollack · University Of Pittsburgh At Pittsburgh · R01 · FY2016 · CA
STAFF INVESTIGATORS
$357,475Leland H Hartwell · Fred Hutchinson Cancer Research Center · P30 · FY2013 · CA
Lipids and Myeloid Cell Function in Cancer
$357,447Dmitry Isaac Gabrilovich · Wistar Institute · R01 · FY2015 · CA
Elucidating time-dependent mechanisms of genetic and epigenetic reprogramming in single cancer cells
$357,404Raul Rabadan · Columbia University Health Sciences · U54 · FY2019 · CA
Expanding the Therapeutic Window of Nanoparticle STING Agonists for Cancer Immunotherapy
$357,393John Tanner Wilson · Vanderbilt University · R01 · FY2023 · CA
Novel Strategies for Cancer Immunotherapy in Stem Cell Transplant
$357,376Yiping Yang · Duke University · R01 · FY2015 · CA
1H NMR STUDIES OF NON-HODGKINS LYMPHOMA
$357,353Jerry D Glickson · University Of Pennsylvania · R01 · FY2009 · CA
Oral Pathogens and Dendritic Cell Subsets
$357,351Christopher W Cutler · State University New York Stony Brook · R01 · FY2010 · DE
Project 3: Developing CAR T Cell Therapies to Target Tumor Heterogeneity in Advanced Prostate Cancer
$357,342Owen N Witte · University Of California Los Angeles · P50 · FY2019 · CA
Biochemistry of Apoptosis in CLL
$357,340John C Reed · University Of California, San Diego · P01 · FY2007 · CA
Project 1: Overcoming Tumor-Induced Immune Suppression to Improve Responses to Immunotherapy
$357,337David G Denardo · Washington University · P50 · FY2016 · CA
Novel Immunotoxin and IGF Therapy for Strabismus
$357,331University Of Minnesota Twin Cities · R01 · FY2004 · EY
Protein Structure/Function by NMR, Crystallography and Computational Chemistry
$357,326Eric Oldfield · University Of Illinois At Urbana-Champaign · R01 · FY2011 · AI
Elucidating time-dependent mechanisms of genetic and epigenetic reprogramming in single cancer cells
$357,308Raul Rabadan · Columbia University Health Sciences · U54 · FY2018 · CA
Project 1: Employing CD11b-Agonists to Render PDAC Responsive to Immunotherapy
$357,273David G Denardo · Washington University · P50 · FY2023 · CA
Lymph Node Alterations in Cancer
$357,254M Alanna Ruddell · Fred Hutchinson Cancer Research Center · R01 · FY2011 · CA
Tissue Factor and Emdometriosis
$357,252Charles Lockwood · Yale University · U54 · FY2010 · HD
The role of TIM3 and CEACAM1 in anti-tumor function of human effector T cells
$357,238Edmund K. Moon · University Of Pennsylvania · R01 · FY2019 · CA
Targeting macrophages for immunotherapy in pancreatic cancer
$357,238Gregory L Beatty · University Of Pennsylvania · R01 · FY2019 · CA
Endocytic Trafficking of ADCs in GBM cancer stem-like cells
$357,223Candece L Gladson · Cleveland Clinic Lerner Com-Cwru · R01 · FY2019 · NS
Local Tumoral Delivered Immune Checkpoint Blockades Immunotherapy and Radioembolization Combination Therapy
$357,212Dong-Hyun Kim · Northwestern University At Chicago · R01 · FY2023 · CA
Transcatheter Intra-Arterial Delivery of Oriented Anti-PD-L1 Immune checkpoint inhibitors Immobilized Nanocarriers for Local Combination Immunotherapy of Hepatocellular Carcinoma
$357,212Dong-Hyun Kim · Northwestern University At Chicago · R01 · FY2024 · CA
Synthetic IL9R signaling to rewire T cells for adoptive cell therapy of cancer
$357,209Anusha Kalbasi · Stanford University · R37 · FY2025 · CA
Regulation of memory CD8 T Cell homeostasis by IL-15Ra+
$357,207Kimberly S Schluns · University Of Tx Md Anderson Can Ctr · R01 · FY2008 · AI
Regulation of memory CD8 T Cell homeostasis by IL-15Ra+
$357,207Kimberly S Schluns · University Of Tx Md Anderson Can Ctr · R01 · FY2009 · AI